PEMAZYRE bemigatinin (tablets)

PEMAZYRE® (pemigatinib)

PEMAZYRE is indicated as monotherapy for the treatment of adults with locally advanced, unresectable or metastatic cholangiocarcinoma with fibroblast growth factor receptor 2 (FGFR2) fusion or rearrangement, that have progressed after at least one line of systemic therapy (see the “Clinical efficacy” section of the Swissmedic Professional Information).1

Show me how this
self⁠–⁠directed learning material works